Navigating the Regulatory Maze: Telemedicine Compliance and Its Impact on Pharmacies and the Public Health
Home Study Webinar
$20 Activity Fee
Topic Designator: 03 – Law | Credit: 1 contact hour Available through February 28, 2028
During the pandemic, telemedicine became the norm. With the arrival of GLP-1 agonists intended for weight loss, direct-to-consumer telemedicine is becoming increasingly popular. From a compliance perspective, however, not all telemedicine models are created equal.
This presentation will describe common compliance issues involving telemedicine that NABP has encountered through its accreditation programs, examine how these issues impact fulfillment pharmacies, and use prominent case studies to demonstrate the risks associated with non-compliant telemedicine models.
This home study webinar is a recording of the live activity that was held on February 13, 2025.
Presenter
Justin Macy, PharmD, JD
Director of Innovation, National Association of Boards of Pharmacy
Justin specializes in the intersection of law, technology, and health care with a focus on pharmacy practice and drug regulation. Recently, Justin helped lead NABP’s Drug Supply Chain Security Act (DSCSA) efforts to support regulators, dispensers, and other trading partners by providing tools and education that enable implementation of DSCSA’s interoperability milestone (Pulse by NABP). Historically, Justin has worked closely with NABP’s Digital Health team. Prior to joining NABP, Justin was a specialist in Amazon’s Consumer Legal department and Associate Director of Innovation for a tech start-up.
